eNews
Trulance® – A New Treatment for Adults with Irritable Bowel Syndrome with Constipation
Drug Review: Volume 22, Issue 6 Irritable bowel syndrome with constipation (IBS-C) is a chronic disorder characterized by abdominal pain, bloating, and altered bowel habits,
Canada Life and ClaimSecure Launch SecurePakTM, First Collaboration Since Acquisition
WINNIPEG, MB, April 4, 2022 /CNW/ – Canada Life and ClaimSecure today announced the launch of SecurePakTM, a bundled offering that includes Canada Life’s insurance benefits and
Firdapse® – The Only Treatment for Adults with Lambert-Eaton Myasthenic Syndrome
Drug Review: Volume 22, Issue 5 Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder that disrupts the connection between nerves and muscles resulting in
Inqovi® – A New Oral Treatment Option for Myelodysplastic Syndromes
Drug Review: Volume 22, Issue 3 Myelodysplastic syndromes (MDS) are a group of bone marrow disorders characterized by ineffective blood cell production which can lead
Forxiga® – Diabetes Drug Now Approved for Chronic Kidney Disease in Patients Without Diabetes
Drug Review: Volume 22, Issue 2 Chronic kidney disease (CKD) is a progressive disease characterized by abnormalities in kidney structure or function that is present
CORZYNA® – A New Add-On Therapy for Stable Angina
Drug Review: Volume 22, Issue 1 Stable angina is a heart condition caused by obstruction or dysfunction to the arteries that supply blood to the